Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid

BACKGROUND: Weight gain is the most frequent adverse effect of valproic acid (VPA) treatment, resulting in poor compliance and many endocrine disturbances. Similarities in the weight change of monozygotic twins receiving VPA strongly suggests that genetic factors are involved in this effect. However...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Neuropsychopharmacol
Main Authors: Li, Hongliang, Wang, Xueding, Zhou, Yafang, Ni, Guanzhong, Su, Qibiao, Chen, Ziyi, Chen, Zhuojia, Li, Jiali, Chen, Xinmeng, Hou, Xiangyu, Xie, Wen, Xin, Shuang, Zhou, Liemin, Huang, Min
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540110/
https://ncbi.nlm.nih.gov/pubmed/25740917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados